entinostat has been researched along with Cutaneous T-Cell Lymphoma in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The extreme photopotency of UVASens allows the use of lower radiation doses minimising the carcinogenic risks associated with the long-term use of phototherapy." | 1.40 | Histone deacetylase inhibitors potentiate photochemotherapy in cutaneous T-cell lymphoma MyLa cells. ( Karagiannis, TC; Sung, JJ; Ververis, K, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sung, JJ | 1 |
| Ververis, K | 1 |
| Karagiannis, TC | 1 |
| Kato, Y | 1 |
| Egusa, C | 1 |
| Maeda, T | 1 |
| Tsuboi, R | 1 |
2 other studies available for entinostat and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
Histone deacetylase inhibitors potentiate photochemotherapy in cutaneous T-cell lymphoma MyLa cells.
Topics: Benzamides; Cell Death; Cell Survival; DNA Damage; DNA Repair; Histone Deacetylase Inhibitors; Human | 2014 |
Combination of retinoid and histone deacetylase inhibitor produced an anti-tumor effect in cutaneous T-cell lymphoma by restoring tumor suppressor gene, retinoic acid receptorβ2, via histone acetylation.
Topics: Acetylation; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Benzoat | 2016 |